Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in Anorexia Nervosa
2024-511681-37-00Phase 2Authorised
- Sponsor
- Centre Hospitalier Sainte-Anne
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anorexia nervosa (AN) comparing Donepezil with Placebo (2 arms). Primary endpoint: Change in total EDE-Q score from baseline to Day 90. Planned start Jun 2024; status: authorised.
02
Drugs
donepezil
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on 2024-511681-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511681-37-00.